Table of Contents
Conference Papers in Medicine
Volume 2013 (2013), Article ID 941364, 6 pages
http://dx.doi.org/10.1155/2013/941364
Conference Paper

Oncothermia as Personalized Treatment Option

1Department of Biotechnics, St. Istvan University, Pater K. u. 1, 2100 Gödöllő, Hungary
2Department of Veterinary Clinical Medicine, Faculty of Veterinary Science, Tottori University, 4-101 Minami, Koyama-Cho, Tottori, Japan
31st Department of Pathology and Experimental Cancer Research, Semmelweis University, Ulloi UCt 26, 1085 Budapest, Hungary

Received 18 January 2013; Accepted 17 April 2013

Academic Editors: G. F. Baronzio, M. Jackson, D. Lee, and A. Szasz

This Conference Paper is based on a presentation given by Oliver Szasz at “Conference of the International Clinical Hyperthermia Society 2012” held from 12 October 2012 to 14 October 2012 in Budapest, Hungary.

Copyright © 2013 Oliver Szasz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Oncothermia is a nanoheating technology personalized for individual status depending on the state, stage, grade, and other personal factors. The guiding line of the treatment keeps the homeostatic control as much effective as possible. One of the crucial points is the surface heat regulation, which has to be carefully done by the electrode systems. The applied stepup heating supports the physiological selection. Recognizing the hysteresis type of SAR-temperature, development of the protocol could be well conducted. Using the Weibull distribution function of the transport processes as well as considering the typical physiological relaxation time of the tissues, special protocols can be developed. It has wide-range applicability for every solid tumor, irrespective of its primary or metastatic form. It could be applied complementary to all the known oncotherapy methods. It is applicable in higher lines of the therapy protocols, even in the refractory and relapsed cases as well.